Cart
sales@molnova.com
Etebenecid
CAS No. 1213-06-5
Etebenecid( Urelim )
Catalog No. M26681 CAS No. 1213-06-5
Etebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 46 | Get Quote |
|
| 100MG | 72 | Get Quote |
|
| 500MG | 177 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtebenecid
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys.
-
DescriptionEtebenecid is uricosuric agents, which lower uric acid levels in the body by increasing the elimination of uric acid by the kidneys. It also inhibits penicillin tubular secretion.
-
In Vitro——
-
In Vivo——
-
SynonymsUrelim
-
PathwayOthers
-
TargetOther Targets
-
Recptorprostaglandin F2α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1213-06-5
-
Formula Weight257.3
-
Molecular FormulaC11H15NO4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (971.59 mM)
-
SMILESCCN(CC)S(=O)(=O)c1ccc(cc1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Vallera C, et al. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol. Anesthesiol Clin. 2017 Jun;35(2):207-219.
molnova catalog
related products
-
Abaloparatide TFA (2...
Abaloparatide TFA (BA 058 TFA) is a parathyroid hormone receptor 1 PTHR1 analogue and an effective and selective activator of the PTHR1 signaling pathway.
-
7-Chloro-4-(piperazi...
7-Chloro-4-(piperazin-1-yl)quinolone is an important scaffold in medicinal chemistry, exhibiting diverse pharmacological profiles either alone or as a hybrid with other active pharmacophores.
-
Efaproxiral Sodium
Efaproxiral Sodium , a synthetic allosteric modifier of hemoglobin, is utilized for brain metastases originating from breast cancer.
